Quasar Medical has announced a definitive agreement with Nordson Corporation to acquire its design and development contract manufacturing businesses located in Galway, Ireland, and Tecate, Mexico. This acquisition aims to bolster Quasar's position as a global leader in the manufacturing of interventional and minimally invasive devices by integrating these facilities into its expanding global platform. The Galway and Tecate sites will enhance Quasar's capabilities in complex balloon and catheter design, rapid prototyping, and cost-effective device assembly. The deal is expected to be finalized in the third quarter of 2025, marking a significant expansion for Quasar Medical's full-lifecycle CDMO platform.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。